World's Best Scientists 2026 revealed!
Iris D. Nagtegaal

Iris D. Nagtegaal

D-Index & Metrics

Medicine

D-Index
102
Citations
56887
World Ranking
7512
National Ranking
291

Iris D. Nagtegaal publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Iris D. Nagtegaal sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 565 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Iris D. Nagtegaal D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Iris D. Nagtegaal sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2020 - Member of Academia Europaea

Overview

Iris D. Nagtegaal is affiliated with Radboud University in the Netherlands and has an extensive record of research primarily in the field of medicine. Their work spans several subfields, including oncology, surgery, pulmonary and respiratory medicine, pathology and forensic medicine, and radiology, nuclear medicine, and imaging.

The focus of Nagtegaal's research covers a range of topics centered on colorectal and gastric cancers. Key areas of study include colorectal cancer screening and detection, colorectal cancer surgical treatments, genetic factors in colorectal cancer, gastric cancer management and outcomes, colorectal cancer treatments and studies, colorectal and anal carcinomas, and the application of radiomics and machine learning in medical imaging.

Nagtegaal has contributed to numerous publications in well-known academic journals, with frequent appearances in:

  • Histopathology
  • Gastroenterology
  • Journal of Crohn's and Colitis
  • Endoscopy
  • Modern Pathology

Their recent papers include:

  • Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial (2020), The Lancet Oncology
  • Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands (2020), The Lancet Oncology
  • Tumour budding in solid cancers (2020), Nature Reviews Clinical Oncology
  • Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer (2020), Journal of Clinical Oncology
  • The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands (2020), Journal of Hematology & Oncology

Frequently collaborating with other researchers, Nagtegaal's common co-authors include:

  • Monique E. van Leerdam
  • Rachel S. van der Post
  • Evelien Dekker
  • Alessandro Lugli
  • Iris Lansdorp-Vogelaar

In recognition of their work, Nagtegaal was named a Member of Academia Europaea in 2020.

Best Publications

  • Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer

    Ellen Kapiteijn;Corrie A.M. Marijnen;Iris D. Nagtegaal;Hein Putter

  • The 2019 WHO classification of tumours of the digestive system.

    Iris D Nagtegaal;Robert D Odze;David Klimstra;Valerie Paradis

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea

  • Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

    Willem van Gijn;Carrie A. M. Marijnen;Iris D. Nagtegaal;Elma Meershoek-Klein Kranenbarg

  • ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    H J Schmoll;E Van Cutsem;A Stein;V Valentini

  • Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

    Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell

  • The TME Trial After a Median Follow-Up of 6 Years: Increased Local Control but No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma

    Koen C. M. J. Peeters;Corrie A. M. Marijnen;Iris D. Nagtegaal;Elma Klein Kranenbarg

  • What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer

    Iris D. Nagtegaal;Phil Quirke

  • Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis

    Geert Litjens;Clara I. Sánchez;Nadya Timofeeva;Meyke Hermsen

  • Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.

    Renu R Bahadoer;Esmée A Dijkstra;Boudewijn van Etten;Corrie A M Marijnen;Corrie A M Marijnen

  • Macroscopic Evaluation of Rectal Cancer Resection Specimen: Clinical Significance of the Pathologist in Quality Control

    Iris D. Nagtegaal;Cornelis J.H. van de Velde;Erik van der Worp;Ellen Kapiteijn

  • Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit.

    Iris D. Nagtegaal;Corrie A. M. Marijnen;Elma Klein Kranenbarg;Cornelis J. H. Van De Velde

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

    Alessandro Lugli;Richard Kirsch;Yoichi Ajioka;Fred Bosman

  • Low Rectal Cancer: A Call for a Change of Approach in Abdominoperineal Resection

    Iris D. Nagtegaal;Cornelius J.H. van de Velde;Corrie A.M. Marijnen;Jan H.J.M. van Krieken

  • Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies

    Sabine Venderbosch;Iris D Nagtegaal;Timothy S Maughan;Christopher G Smith

  • BRAF mutation in metastatic colorectal cancer.

    Jolien Tol;Iris D Nagtegaal;Cornelis J A Punt

  • Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands.

    Avinash G Dinmohamed;Avinash G Dinmohamed;Otto Visser;Rob H A Verhoeven;Marieke W J Louwman

  • EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum

    Cornelis J.H. Van De Velde;Petra G. Boelens;Josep M. Borras;Jan Willem Coebergh

  • DUTCH COLORECTAL CANCER GROUP. PREOPERATIVE RADIOTHERAPY COMBINED WITH TOTAL MESORECTAL EXCISION FOR RESECTABLE RECTAL CANCER

    E Kapiteijn;C A Marijnen;I D Nagtegaal;H Putter

Frequent Co-Authors

Corrie A.M. Marijnen
Corrie A.M. Marijnen Leiden University Medical Center
Cornelis J. A. Punt
Cornelis J. A. Punt University of Amsterdam
Cornelis J.H. van de Velde
Cornelis J.H. van de Velde Leiden University Medical Center
Alessandro Lugli
Alessandro Lugli University of Bern
Pieter J. Tanis
Pieter J. Tanis University of Amsterdam
Bauke Ylstra
Bauke Ylstra Vrije Universiteit Amsterdam
Nicoline Hoogerbrugge
Nicoline Hoogerbrugge Radboud University
Philip Quirke
Philip Quirke University of Leeds
Regina G. H. Beets-Tan
Regina G. H. Beets-Tan Antoni van Leeuwenhoek Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA doesn’t only mean becoming a doctor—there are many online degree paths and related careers that can help you join the healthcare field quickly and affordably. For registered nurses seeking advancement, you can find some of the cheapest rn to bsn online programs, allowing you to complete your BSN degree on a budget while balancing work and study.

If you’re a non-nursing graduate considering a fast track to advanced practice, direct entry nurse practitioner programs for non-nurses online could be a direct route to a rewarding career. There are also easy nursing programs to get into for those just starting out, offering more flexible admissions.

For those interested in healthcare administration or behind-the-scenes work, consider medical billing and coding schools online with financial aid opportunities. These alternative pathways can lead to stable, in-demand roles within the medical sector, and most programs offer flexible online study options.

Best Scientists Citing Iris D. Nagtegaal

Trending Scientists

Recently Published Articles